Actively Recruiting
Blood Flow Restriction Exercise in Patients With an Achilles Tendon Rupture
Led by University of Aarhus · Updated on 2025-04-17
218
Participants Needed
1
Research Sites
153 weeks
Total Duration
On this page
Sponsors
U
University of Aarhus
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to gain insights into the effects of Blood Flow Restriction Exercise (BFRE) in patients with an acute Achilles tendon Rupture. The main questions it aims to answer are: Is BFRE an effective adjunct to usual care when compared with only usual care? When is the optimal timing for initiating BFRE: In the early treatment stage or at the later stage after hospital treatment? Participants will receive an intervention comprising 12 weeks of BFRE as an adjunct to usual care. * Either in the initial 1-12 weeks after Achilles tendon rupture, or * In the following 13-24 weeks after Achilles tendon rupture Researchers will compare the two groups at 13 weeks (3 months) to compare BFRE to usual care, and at 25 weeks (6 months) to compare the two time points for initiating BFRE (early vs. late).
CONDITIONS
Official Title
Blood Flow Restriction Exercise in Patients With an Achilles Tendon Rupture
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Started initial treatment within 72 hours of Achilles tendon rupture
- Understand written and spoken Danish
You will not qualify if you...
- Bilateral Achilles tendon rupture
- Previous Achilles tendon rupture in either leg
- Decreased lower extremity function from conditions other than Achilles tendon rupture
- Treated with fluoroquinolones within the last six months
- Treated with corticosteroid injections near the Achilles tendon within the last six months
- Diabetes
- Previous diagnosed thrombosis
- Known atherosclerosis in peripheral arteries of the lower limb
- Other exclusion reasons (cognitive deficits, inability to consent, requiring cast treatment due to low compliance)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aarhus University Hospital
Aarhus N, Denmark, 8200
Actively Recruiting
Research Team
A
Andreas Bentzen, MHSc
CONTACT
I
Inger Mechlenburg, DMSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here